Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | NU7026 |
Synonyms | |
Therapy Description |
NU7026 is an ATP-competitive inhibitor of DNA-PKcs, which may increase sensitivity of tumor cells to radiotherapy (PMID: 26716839, PMID: 16249792, PMID: 32194286). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
NU7026 | DNA_PK Inhibitor 9 | NU7026 is an ATP-competitive inhibitor of DNA-PKcs, which may increase sensitivity of tumor cells to radiotherapy (PMID: 26716839, PMID: 16249792, PMID: 32194286). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|